EFFECTS OF 2-METHOXYMETHYL-17-ALPHA-METHYLESTRADIOL-3-METHYL ETHER ON EXPERIMENTAL HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS IN ANIMALS.
D000311:Adrenal Glands; D000818:Animals; D001011:Aorta; D001161:Arteriosclerosis; D050197:Atherosclerosis; D001769:Blood; D002784:Cholesterol / Q000097:blood*; D004967:Estrogens; D006937:Hypercholesterolemia; D006949:Hyperlipidemias; D008055:Lipids / Q000097:blood*; D008099:Liver; D008738:Methyl Ethers; D051379:Mice; D010600:Pharmacology; D010743:Phospholipids; D011817:Rabbits; D051381:Rats; D012106:Research; D013501:Surface-Active Agents
D004967:Estrogens; D008055:Lipids; D008738:Methyl Ethers; D010743:Phospholipids; D013501:Surface-Active Agents; D002784:Cholesterol
ADRENAL GLANDS; AORTA; ARTERIOSCLEROSIS; BLOOD; BLOOD CHOLESTEROL; BLOOD LIPIDS; CHOLESTEROL; ESTROGENS; EXPERIMENTAL LAB STUDY; HYPERCHOLESTEREMIA; HYPERLIPEMIA; LIPIDS; LIVER; MICE; PHARMACOLOGY; PHOSPHOLIPIDS; RABBITS; RATS; SURFACE-ACTIVE AGENTS